Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label Palbociclib. Show all posts
Showing posts with label Palbociclib. Show all posts
Wednesday, May 11, 2016

Pfizer Receives Expanded FDA Approval For Ibrance (palbociclib) In HR , HER2- Metastatic Breast Cancer

›
In continuation of my updates on palbociclib Pfizer Inc. (NYSE:PFE) announced that the U.S. Food and Drug Administration (FDA) h...
Tuesday, March 29, 2016

New oral breast cancer drug has potential to combat other types of cancer

›
In continuation of my update on  Palbociclib Palbociclib, a new oral drug whose efficacy in combating breast cancer has been demon...
Friday, March 25, 2016

New Breast Cancer Drug May Be Effective Against Other Types of Cancer, Abramson Cancer Center Experts Find

›
In continuation of my update on  Palbociclib , Palbociclib, a new oral drug whose efficacy in combating breast cancer has been ...
Monday, September 21, 2015

PALOMA3 supports palbociclib use in advanced breast cancer

›
In continuation of my update on palbociclib ...  Advanced breast cancer patients who have failed prior endocrine treatment may rece...
Friday, May 1, 2015

Palbociclib extends progression-free survival in advanced breast cancer patients

›
In continuation of my update on Palbociclib Palbociclib, an investigational oral medication that works by blocking molecules responsib...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.